Literature DB >> 21123768

Use of patient-reported outcomes in medical product development: a report from the 2009 NEI/FDA Clinical Trial Endpoints Symposium.

Rohit Varma1, Elaine A Richman, Frederick L Ferris, Neil M Bressler.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21123768      PMCID： PMC3055746          DOI： 10.1167/iovs.10-5627

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN： 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  28 in total

1.  Quality of life in keratoconus.

Authors:  Steven M Kymes; Jeffrey J Walline; Karla Zadnik; Mae O Gordon
Journal:  Am J Ophthalmol       Date:  2004-10       Impact factor: 5.258

2.  Treatment and vision-related quality of life in the early manifest glaucoma trial.

Authors:  Leslie G Hyman; Eugene Komaroff; Anders Heijl; Bo Bengtsson; M Cristina Leske
Journal:  Ophthalmology       Date:  2005-09       Impact factor: 12.079

3.  Comparison of the results of first and second cataract eye surgery.

Authors:  X Castells; J Alonso; C Ribó; A Casado; J A Buil; M Badia; M Castilla
Journal:  Ophthalmology       Date:  1999-04       Impact factor: 12.079

4.  The relationship of self-rated vision and hearing to functional status and well-being among seniors 70 years and older.

Authors:  P Lee; J P Smith; R Kington
Journal:  Am J Ophthalmol       Date:  1999-04       Impact factor: 5.258

5.  Patient outcomes of refractive surgery. The refractive status and vision profile.

Authors:  O D Schein; S Vitale; S D Cassard; E P Steinberg
Journal:  J Cataract Refract Surg       Date:  2001-05       Impact factor: 3.351

Review 6.  Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review.

Authors:  Mary Kay Margolis; Karin Coyne; Tessa Kennedy-Martin; Timothy Baker; Oliver Schein; Dennis A Revicki
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

7.  Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision.

Authors:  R W Massof; D C Fletcher
Journal:  Vision Res       Date:  2001-02       Impact factor: 1.886

8.  The impact of visual impairment on self-reported visual functioning in Latinos: The Los Angeles Latino Eye Study.

Authors:  Denise R Globe; Joanne Wu; Stanley P Azen; Rohit Varma
Journal:  Ophthalmology       Date:  2004-06       Impact factor: 12.079

9.  Development of the 'Activities of Daily Vision Scale'. A measure of visual functional status.

Authors:  C M Mangione; R S Phillips; J M Seddon; M G Lawrence; E F Cook; R Dailey; L Goldman
Journal:  Med Care       Date:  1992-12       Impact factor: 2.983

10.  National study of cataract surgery outcomes. Variation in 4-month postoperative outcomes as reflected in multiple outcome measures.

Authors:  E P Steinberg; J M Tielsch; O D Schein; J C Javitt; P Sharkey; S D Cassard; M W Legro; M Diener-West; E B Bass; A M Damiano
Journal:  Ophthalmology       Date:  1994-06       Impact factor: 12.079
View more
  17 in total

1.  Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function.

Authors:  Robert N Weinreb; Paul L Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-04       Impact factor: 4.799

Review 2.  Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid?

Authors:  Robert Battat; Parambir S Dulai; Christopher Ma; Vipul Jairath; Brian G Feagan; William J Sandborn; Reena Khanna
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-04

3.  Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.

Authors:  Jennifer Rose-Nussbaumer; N Venkatesh Prajna; K Tiruvengada Krishnan; Jeena Mascarenhas; Revathi Rajaraman; Muthiah Srinivasan; Anita Raghavan; Catherine E Oldenburg; Kieran S O'Brien; Kathryn J Ray; Stephen D McLeod; Travis C Porco; Thomas M Lietman; Nisha R Acharya; Jeremy D Keenan
Journal:  JAMA Ophthalmol       Date:  2015-06       Impact factor: 7.389

Review 4.  Neuroprosthetics and the science of patient input.

Authors:  Heather L Benz; Eugene F Civillico
Journal:  Exp Neurol       Date:  2016-07-22       Impact factor: 5.330

5.  Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.

Authors:  Jennifer Rose-Nussbaumer; N Venkatesh Prajna; Tiruvengada Krishnan; Jeena Mascarenhas; Revathi Rajaraman; Muthiah Srinivasan; Anita Raghavan; Catherine E Oldenburg; Kieran S O'Brien; Kathryn J Ray; Travis C Porco; Stephen D McLeod; Nisha R Acharya; Jeremy D Keenan; Thomas M Lietman
Journal:  Br J Ophthalmol       Date:  2015-11-03       Impact factor: 4.638

6.  Assessment of the Incorporation of Patient-Centric Outcomes in Studies of Minimally Invasive Glaucoma Surgical Devices.

Authors:  Jimmy T Le; Shilpa Viswanathan; Michelle E Tarver; Malvina Eydelman; Tianjing Li
Journal:  JAMA Ophthalmol       Date:  2016-09-01       Impact factor: 7.389

7.  Patient experiences in retinal trials: a cross-sectional study.

Authors:  Cheryl Pui-Yan Au; Nicole Fardell; Maria Williams; Samantha Fraser-Bell; Anna Campain; Mark Gillies
Journal:  BMC Ophthalmol       Date:  2015-07-23       Impact factor: 2.209

8.  The importance of rating scales in measuring patient-reported outcomes.

Authors:  Jyoti Khadka; Vijaya K Gothwal; Colm McAlinden; Ecosse L Lamoureux; Konrad Pesudovs
Journal:  Health Qual Life Outcomes       Date:  2012-07-13       Impact factor: 3.186

Review 9.  The challenges in improving outcome of cataract surgery in low and middle income countries.

Authors:  Robert Lindfield; Kalluru Vishwanath; Faustin Ngounou; Rohit C Khanna
Journal:  Indian J Ophthalmol       Date:  2012 Sep-Oct       Impact factor: 1.848

10.  Diagnosing the severity of dry eye: a clear and practical algorithm.

Authors:  Christophe Baudouin; Pasquale Aragona; Gysbert Van Setten; Maurizio Rolando; Murat Irkeç; José Benítez del Castillo; Gerd Geerling; Marc Labetoulle; Stefano Bonini
Journal:  Br J Ophthalmol       Date:  2014-03-13       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.